GENALICE and deCODE Genetics enter into a partnership for population wide genomic analysis
GENALICE announced it is partnering with deCODE Genetics to facilitate the large-scale testing of its unique DNA data processing software solution, GENALICE MAP. After a first successful round of evaluating GENALICE MAP on speed and quality, both parties agreed to extend the evaluation to include up to 10,000 full human genomes.
Population wide analysis is crucial if the potential of whole genome sequencing for medical application in patients with complex diseases is to be realized. Data processing at that level represents a major challenge, however, GENALICE’s unique ability to process a full human genome on general purpose hardware in a matter of minutes makes population wide sequence variation analysis a reality.
The project will kick off in August and final results are expected to be ready in December this year. Hans Karten, CEO/CTO of GENALICE, stated: “deCODE's unique dataset enables us to verify the quality of the output at population scale. GENALICE MAP is the only DNA data processing solution currently on the market that is capable of swiftly processing the huge quantities of data produced by the modern high volume sequencers with great accuracy but limited hardware requirements
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
